Eight of the schwannomas (50%) had NF2 sequence mutations detected by PCR/dHPLC, and 10 of the schwannomas (62%) had NF2 sequence mutations detected by the combined MLPA and PCR/dHPLC analysis. The gene discussed is NF2; the disease is schwannoma.